Novopharma Plus
Registered as a joint venture in July 2002 and based in Tashkent, Novopharma Plus JV LLC is backed by substantial foreign equity investments from offshore holdings, including Treponiti Tower Limited and Bazar Vista Limited. Its early development program covered production facilities, equipment installation, and the creation of a testing laboratory during 2001–2004. In 2007, Novopharma Plus achieved a historic milestone by becoming the first-ever pharmaceutical manufacturer in Uzbekistan to be awarded international Good Manufacturing Practice (GMP) standards.
The company’s products appear in Uzbekistan’s pharmaceutical registration records, including injectable formulations. This manufacturing background places it within the country’s established network of finished medicine producers. A published historical company profile records quality management certification obtained in June 2013 for development, manufacturing, and distribution. Its evolution reflects a highly successful combination of production infrastructure, quality systems, and foreign strategic investment required to build a modern pharmaceutical business.